[Primary aldosteronism].

Abstract

Primary aldosteronism affects 6% of hypertensive patients. The diagnosis should be suspected in any patient with severe or resistant hypertension or hypertension associated with hypokalemia. The screening test consists on the assessment of the aldosterone to renin ratio. In case of an elevated ratio, the diagnosis of primary aldosteronism is confirmed by either elevated concentrations of basal plasma and/or urinary aldosterone or absence of suppression of aldosterone during dynamic test (including the saline infusion test). CT aims to ensure the absence of adrenal carcinoma and to study the morphology of the adrenals. The unilateral or bilateral type of aldosterone secretion is based on the realization of an adrenal venous sampling. When the hypersecretion is unilateral, the treatment consists of adrenalectomy leading to cure of hypertension in 42% of cases, improvement in 40% of cases. For patient with bilateral disease or who don't want to undergo surgery, treatment is based on spironolactone usually at doses of 25 or 50 mg in combination with other antihypertensives drugs such as diuretics or calcium channel blockers.

• Authors: Laurence Amar
• Journal: La Revue du praticien (Rev Prat) Vol. 65 Issue 6 Pg. 817-21 (Jun 2015) ISSN: 0035-2640 [Print] France
• Vernacular Title: Hyperaldostéronisme primaire.
• PMID: 26298907 (Publication Type: English Abstract, Journal Article)

Chemical References

• Antihypertensive Agents
• Calcium Channel Blockers
• Aldosterone
• Renin

Topics

• Adrenal Cortex Neoplasms (diagnosis, surgery)
• Adrenalectomy
• Adrenocortical Adenoma (diagnosis, surgery)
• Aldosterone (analysis)
• Algorithms
• Antihypertensive Agents (therapeutic use)
• Calcium Channel Blockers (therapeutic use)
• Humans
• Hyperaldosteronism (diagnosis, etiology, therapy)
• Hypertension (etiology, therapy)
• Hypokalemia (diagnosis)
• Renin (analysis)